| scholarly article | Q13442814 |
| P2093 | author name string | Kuwabara A | |
| Sato K | |||
| Nochi H | |||
| Tamoto K | |||
| Kondo Y | |||
| Ui M | |||
| Tomura H | |||
| Okajima F | |||
| Tokumitsu Y | |||
| P2860 | cites work | Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 | Q24314828 |
| Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids | Q24316056 | ||
| Lysophosphatidic acid, a multifunctional phospholipid messenger | Q28302384 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis | Q33567912 | ||
| Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells | Q34128848 | ||
| Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes | Q34172169 | ||
| A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction | Q35296197 | ||
| Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
| Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity | Q36048670 | ||
| Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. | Q36791667 | ||
| Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C | Q37111176 | ||
| Oxidized low density lipoprotein suppresses activation of NF kappa B in macrophages via a pertussis toxin-sensitive signaling mechanism | Q38298577 | ||
| Role of secretory phospholipases A2 in the pathobiology of disease | Q39744076 | ||
| Role of oxidized low density lipoprotein in atherogenesis | Q40343074 | ||
| Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways | Q40867323 | ||
| The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. | Q41157346 | ||
| Sphingolipid metabolism and cell growth regulation. | Q41198130 | ||
| Potential involvement of type II phospholipase A2 in atherosclerosis | Q41554170 | ||
| Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells | Q41665885 | ||
| Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung | Q41699178 | ||
| Pertussis toxin produces differential inhibitory effects on basal, P2-purinergic, and chemotactic peptide-stimulated inositol phospholipid breakdown in HL-60 cells and HL-60 cell membranes | Q41721162 | ||
| Relationship between agonist binding, phosphorylation and immunoprecipitation of the m3-muscarinic receptor, and second messenger responses | Q41889691 | ||
| Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. | Q42060867 | ||
| P2-purinergic agonists activate phospholipase C in a guanine nucleotide- and Ca2+-dependent manner in FRTL-5 thyroid cell membranes | Q45269889 | ||
| The production of nitric oxide in endothelial cells by amphiphiles | Q46803907 | ||
| Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins | Q59060592 | ||
| Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients. | Q64894785 | ||
| Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells | Q67505751 | ||
| Discrimination between two types of P2 purinoceptors by suramin in rat hepatocytes | Q67554530 | ||
| Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation | Q67573946 | ||
| Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction | Q68328403 | ||
| A permissive role of pertussis toxin substrate G-protein in P2-purinergic stimulation of phosphoinositide turnover and arachidonate release in FRTL-5 thyroid cells. Cooperative mechanism of signal transduction systems | Q69353251 | ||
| Inhibition by islet-activating protein, pertussis toxin, of P2-purinergic receptor-mediated iodide efflux and phosphoinositide turnover in FRTL-5 cells | Q69832927 | ||
| Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction | Q70090065 | ||
| Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids. Subspecies difference | Q70634617 | ||
| Involvement of pertussis toxin-sensitive GTP-binding proteins in sphingosine 1-phosphate-induced activation of phospholipase C-Ca2+ system in HL60 leukemia cells | Q71006808 | ||
| Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors | Q71056560 | ||
| An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2 | Q71570793 | ||
| Analysis of lysophophatidylcholine-induced endothelial dysfunction | Q71698791 | ||
| Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine | Q71702928 | ||
| Lysophosphatidylcholine stimulates phospholipase D in human coronary endothelial cells: role of PKC | Q71738295 | ||
| The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation | Q71762941 | ||
| Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids | Q71823894 | ||
| Activation of Nitric Oxide Synthase from Cultured Aortic Endothelial Cells by Phospholipids | Q72100677 | ||
| Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta | Q72101285 | ||
| Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells | Q72290621 | ||
| Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C | Q72314416 | ||
| Oxidized low-density lipoprotein stimulates nitric oxide release by rabbit aortic endothelial cells | Q72548757 | ||
| Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages | Q72878716 | ||
| Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages | Q73086093 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| fatty acid | Q61476 | ||
| P304 | page(s) | 491-500 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells | |
| P478 | volume | 336 ( Pt 2) |
| Q45073332 | Formation of transient non-protein calcium pores by lysophospholipids in S49 Lymphoma cells |
| Q40633092 | Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors |
| Q38368000 | LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes |
| Q54642538 | Lysophosphatidylcholine enhances IKs currents in cardiac myocytes through activation of G protein, PKC and Rho signaling pathways |
| Q92836682 | Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma |
| Q28215211 | Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4 |
| Q28238163 | Therapeutic effects of lysophosphatidylcholine in experimental sepsis |
Search more.